Patientenforschung
Anmelden
Alle Studien
Aktiv, aber nicht rekrutierendBEOBACHTEND

A Prospective Natural History Study in Uveal Melanoma

This study is building a comprehensive database, like a medical diary, to track people with uveal melanoma, a type of eye cancer. Doctors want to understand the full journey of this disease, from when it's first found, through different treatments, and if it comes back elsewhere in the body. This record will involve information from eye cancer specialists and medical oncologists working together across different hospitals. By collecting this detailed information over time, researchers hope to gain crucial insights into how uveal melanoma behaves. This knowledge is vital for developing new and more effective treatments in the future and ultimately improving the lives of those affected by this rare condition.

Auf einen Blick

Status
Aktiv, aber nicht rekrutierend
Sponsor
Columbia University
Einschreibeziel
122
Starten
06 May 2021
Geschätzte Fertigstellung
01 Mär 2027
Uveales Melanom

Worum geht es in dieser Studie?

Uveal melanoma is a rare type of cancer that starts in the eye. While it's the most common cancer inside the eye, it's very rare overall. This study aims to create a comprehensive record, called a registry, of people living with uveal melanoma. Think of it as a detailed, ongoing medical diary for many patients, following their journey from diagnosis through treatment and any re-occurrence.

Currently, there isn't one big, ongoing study collecting all this important information in a consistent way. This new registry is designed to fill that gap. Doctors from different specialist areas, including eye cancer specialists (ophthalmologic oncologists) and cancer specialists (medical oncologists), often work together to care for patients with uveal melanoma. This study brings these experts together to make sure that the registry captures a complete picture of the disease's progression.

The main goal is to understand the 'natural history' of uveal melanoma – how it typically develops, what kind of treatments are used at different stages, and how patients respond over time. By gathering this detailed information from many patients, researchers hope to learn more about the disease. This knowledge is absolutely vital for designing future studies and developing new, more effective therapies to improve treatment and outcomes for people with uveal melanoma.

Wichtige Erkenntnisse

  • This study creates a vital database for uveal melanoma, a rare eye cancer.
  • It collects medical information to understand the disease's full journey.
  • The goal is to improve future treatments and patient care.
  • Participation involves sharing your routine medical data, not new interventions.
  • Your data's privacy is rigorously protected.
  • You can withdraw from the study at any time without impacting your care.

Wer könnte berechtigt sein?

To be part of this study, you would need to have been diagnosed with uveal melanoma. This registry is open to adults aged 18 years and older; there is no upper age limit.

Participation usually involves giving your written permission (consent) for your medical information to be included in the registry. In some cases, your hospital's review board (IRB/ethics committee) might allow your information to be used anonymously if you can't provide written consent, or for information already collected from your past medical records.

There are no specific reasons that would prevent you from taking part, other than not having a diagnosis of uveal melanoma or not being able to provide consent (unless a waiver is in place).

Könnte diese Studie für Sie geeignet sein?

Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.

  1. Have I been diagnosed with uveal melanoma?
  2. Bin ich 18 Jahre alt oder älter?
  3. Am I able to provide consent for my medical information to be used?
  4. Has my doctor mentioned this registry as part of my ongoing care?
Beantworten Sie jede Frage, um Ihr Ergebnis zu sehen.

Was beinhaltet die Teilnahme?

Taking part in this study is different from a typical clinical trial where you might receive experimental medication. This study is observational, meaning it mostly involves collecting information from your routine medical care for uveal melanoma. You wouldn't need to attend extra visits or have additional assessments beyond what your doctors already recommend.

The study would involve your medical information, such as your diagnosis, treatments you receive, how you respond to those treatments, and any follow-up care, being collected and added to the registry by your healthcare team. This process continues throughout your journey with uveal melanoma, following the disease's natural course. You would not receive any specific medication or intervention as part of this study itself.

Potenzielle Risiken und Vorteile

The potential benefits of taking part in this registry are not directly to you as an individual, as it doesn't involve new treatments. However, by contributing your information, you help researchers better understand uveal melanoma, which could lead to improved treatments and outcomes for future patients. There are minimal risks involved, mainly related to the privacy of your medical information, though strict measures are in place to protect your data. You are always free to withdraw your consent and participation from the registry at any time without it affecting your medical care.

Standorte (17)

  • Massachusetts General Hospital
    Verifizierte Postleitzahl
    Boston, Vereinigte Staaten
  • Memorial Sloan Kettering Cancer Center
    Verifizierte Postleitzahl
    New York, Vereinigte Staaten
  • Thomas Jefferson University Hospital
    Verifizierte Postleitzahl
    Philadelphia, Vereinigte Staaten
  • MD Anderson Krebszentrum
    Verifizierte Postleitzahl
    Houston, Vereinigte Staaten
  • Royal Adelaide Hospital
    Verifizierte Postleitzahl
    Adelaide, Australia
  • Chatswood Eye Specialists
    Verifizierte Postleitzahl
    Chatswood, Australia
  • Royal Victorian Eve and Ear Hospital
    Verifizierte Postleitzahl
    East Melbourne, Australia
  • Western Eye Specialists
    Verifizierte Postleitzahl
    Maribyrnong, Australia
  • Pennington Eye Clinic
    Verifizierte Postleitzahl
    North Adelaide, Australia
  • Perth Retina
    Verifizierte Postleitzahl
    Subiaco, Australien
  • Dr. Conway Private Rooms
    Verifizierte Postleitzahl
    Sydney, Australien
  • St. Vincent's Hospital
    Verifizierte Postleitzahl
    Sydney, Australien

Häufige Fragen

What is uveal melanoma?

Uveal melanoma is a rare type of cancer that develops in the uvea, the middle layer of your eye.

Will I receive new treatments in this study?

No, this study is about collecting information from your standard care, not providing new treatments.

Who will have access to my medical information?

Only authorized researchers and medical staff involved in the study will have access, and your data will be kept confidential.

Wie lange werde ich Teil dieser Studie sein?

The study aims to follow the full journey of uveal melanoma, so your information would be collected over an extended period as part of your ongoing care.

Kann ich die Teilnahme beenden, wenn ich meine Meinung ändere?

Yes, you can withdraw your consent to participate at any time, and it will not affect your medical care.

Wie Sie mehr erfahren können

Offizielles Gerichtsprotokoll

Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.

Diskussion

Community-Diskussion

Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.